Delphi advisor to AddLife in the acquisition of advanced surgery business

Delphi has advised AddLife AB (publ) and its subsidiary AddLife Development AB in the acquisition of SIAD Healthcare s.p.a. business in the product area of advanced surgery.

AddLife is an independent distributor within Life Science that offer high-quality products, services and advice to both the private and public sectors. The corporation develops and acquires profitable companies in selected niche areas in the segments diagnostics, biomedical research and laboratory analysis and medtech. In 2019, AddLife had a turnover of SEK 3,479 million.

SIAD Healthcare s.p.a. markets and sells products from leading suppliers in advanced surgery, such as neurosurgery, spinal surgery, plastic surgery, interventional radiology, as well as products for advanced wound care. In conjunction with the acquisition, the business will be transferred to a newly formed company, which AddLife is acquiring. The business has sales of approximately EUR 8 million on the Italian market in a segment in which AddLife is already an established supplier on the Nordic and central-European markets.

Delphi has been lead counsel in the acquisition and cooperated with the law firm NCTM Studio Legale in Italy.

Delphi’s team mainly consisted of Fredrik Mörner as responsible partner with assistance from several other lawyers at Delphi.